State and Trait Anxiety Scores of Patients Receiving Intravitreal Injections.
State and Trait Anxiety Scores of Patients Receiving Intravitreal Injections.
复制标题
DOI：
10.1159/000478993
复制
发表时间：
2017-05-01
期刊：
影响因子：
--
通讯作者：
Deveci, Artuner
中科院分区：
文献类型：
--
作者：
Kayikcioglu, Ozcan;Bilgin, Sinan;Deveci, Artuner
背景技术背景：评估接受玻璃体内注射的患者的状态和特质焦虑评分的参数。所有受试者均接受玻璃体内雷珠单抗或贝伐单抗注射。结果：有经验患者的平均状态焦虑评分为45.19 ± 5.62，无经验患者的平均状态焦虑评分为43.10 ± 6.62（p = 0.078）。有经验患者的平均特质焦虑评分为50.14 ± 6.62，无经验患者的平均特质焦虑评分为49.17 ± 10.79（p = 0.810）。此外，男性与女性、在职与退休患者的状态焦虑和特质焦虑得分差异均无统计学意义（p > 0.05）。结论：焦虑可能不因社会人口学状况而表现出显著差异。在这项研究中发现的高焦虑分数也强调了医疗保健提供者应该在治疗过程中努力降低焦虑水平。
BACKGROUND: To evaluate parameters on the state and trait anxiety scores of patients receiving intravitreal injections.METHODS: One hundred thirteen patients were included in the study. All subjects received intravitreal ranibizumab or bevacizumab injections. To measure the level of anxiety, Spielberg's State-Trait Anxiety Inventory questionnaire was used.RESULTS: The mean state anxiety scores were 45.19 ± 5.62 in experienced patients and 43.10 ± 6.62 in inexperienced patients (p = 0.078). The mean trait anxiety scores were 50.14 ± 6.62 in experienced patients and 49.17 ± 10.79 in inexperienced patients (p = 0.810). Additionally, there was no statistically significant difference in the state and trait anxiety scores between the male and female, employed, and retired patients (p > 0.05).CONCLUSION: Anxiety may not show significant differences according to sociodemographic status. High anxiety scores found in this study also emphasize that health care providers should try to decrease anxiety levels during the course of treatment.